Objective: Mental recovery in patients with cancer involves a dynamic and comprehensive process. This study aimed to develop and validate the Mental Recovery Scale (MRS) to comprehensively assess mental recovery in patients with cancer and evaluate its psychometric properties. Methods: Based on literature review, patient interviews, and expert input, an initial 87-item pool was refined to 27 items after content validity evaluation. Data were collected from 300 patients with cancer in Türkiye. Exploratory and confirmatory factor analyses assessed the scale’s structure, while reliability and convergent validity were tested using Cronbach’s alpha, test–retest, intraclass correlation, and correlations with the Subjective Recovery Assessment Scale (SubRAS). Results: The content validity index of the scale was 0.96, and the Kaiser–Meyer–Olkin (KMO) value was 0.94. Three items were removed during exploratory factor analysis (EFA), and the final scale consisted of 24 items with a single-factor structure explaining 50.3% of the variance (factor loadings: 0.53-0.84). Confirmatory factor analysis showed acceptable model fit (χ2/df=2.63, comparative fit ındex =0.91, root mean square error of approximation=0.07). The Cronbach’s alpha coefficient was 0.95, and the test–retest intraclass correlation coefficient was 0.831. A strong correlation was found between the scale and the SubRAS (r=0.89, P < .001). Conclusions: The MRS is a valid, reliable, and culturally appropriate tool that captures the integrated nature of mental recovery in patients with cancer. The MRS can guide oncology nurses in promptly identifying patients’ recovery needs and implementing targeted psychosocial interventions. By incorporating the scale into routine care, nurses can deliver more holistic, recovery-oriented services that acknowledge the individuality of each patient’s experience.